Towards integrated drug substance and drug product design for an active pharmaceutical ingredient using particle engineering.
A novel experimental approach describing the integration of drug substance and drug production design using particle engineering techniques such as sonocrystallization, high shear wet milling (HSWM) and dry impact (hammer) milling were used to manufacture samples of an active pharmaceutical ingredient (API) with diverse particle size and size distributions. The API instability was addressed using particle engineering and through judicious selection of excipients to reduce degradation reactions. API produced using a conventional batch cooling crystallization process resulted in content uniformity issues. Hammer milling increased fine particle formation resulting in reduced content uniformity and increased degradation compared to sonocrystallized and HSWM API in the formulation. To ensure at least a 2-year shelf life based on predictions using an Accelerated Stability Assessment Program, this API should have a D [v, 0.1] of 55 μm and a D [v, 0.5] of 140 μm. The particle size of the chief excipient in the drug product formulation needed to be close to that of the API to avoid content uniformity and stability issues but large enough to reduce lactam formation. The novel methodology described here has potential for application to other APIs.
tkougoulos@novanonline.com
Eleftherios
E
Kougoulos
Ian
I
Smales
Hugh M
HM
Verrier
D001698:Biomedical Engineering / Q000379:methods*; D003460:Crystallization; D004304:Dosage Forms; D004339:Drug Compounding; D015195:Drug Design; D004345:Drug Industry; D004355:Drug Stability; D005079:Excipients / Q000737:chemistry; D006801:Humans; D008353:Mannitol / Q000737:chemistry*; D010316:Particle Size; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D013627:Talc / Q000737:chemistry*
D004304:Dosage Forms; D005079:Excipients; D004364:Pharmaceutical Preparations; D013627:Talc; D008353:Mannitol
J Pharm Sci. 2009 Jan;98(1):239-47
18428197
Adv Drug Deliv Rev. 2004 Feb 23;56(3):349-69
14962586
J Pharm Sci. 2010 Jan;99(1):51-75
19521966
Int J Pharm. 2008 Oct 1;362(1-2):109-17
18652883
Pharm Res. 2007 Apr;24(4):780-90
17372701
Pharm Res. 1990 Sep;7(9):962-6
2235898
J Pharm Sci. 1982 Feb;71(2):188-90
7062242
Pharm Res. 1996 Dec;13(12):1795-8
8987073
Ultrason Sonochem. 2007 Sep;14(6):717-24
17254828
Pharm Res. 2007 Feb;24(2):203-27
17191094
J Pharm Sci. 2006 May;95(5):1049-59
16552749
Int J Pharm. 2006 Aug 31;320(1-2):23-9
16759826